MS

Mount Sinai Hospital, Toronto at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Mount Sinai Hospital, Toronto brings 1 presentation to AMP 2026 in Seattle. Its contribution sits in genetics, covering multimodal deep learning to strengthen polygenic risk scores and move them into molecular diagnostics.

OrganizationAMP 2026 Attendance
MS
Mount Sinai Hospital, Toronto
Toronto, Canada
Med centres
Teaching hospital in Toronto affiliated with the University of Toronto, part of Sinai Health, with prenatal and clinical genetics diagnostics.
Session
Thu, Nov 12
10:15am–11:45am
Multimodal Deep Learning to Supercharge Polygenic Risk Scores: From Research Breakthroughs to Molecular Diagnostics Implementation
Genetics
  1. 10:15am–10:45amGenetically Anchored Protein Networks: Mapping Inherited Risk onto Brain BiologyUniversity of California, Davis
  2. 10:45am–11:15amPopulation Genetics in an Era of Genomic HealthIcahn School of Medicine at Mount Sinai
  3. 11:15am–11:45amBeyond Single-Modality Genomic Risk AssessmentYale University School of Medicine

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Mount Sinai Hospital, Toronto

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction